← Back to Search

Tele-Behavioral Activation + Fall Prevention for Depression (TBF Trial)

N/A
Recruiting
Led By Namkee G Choi
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 50+
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up monthly (form 12 weeks to 36 weeks)
Awards & highlights

TBF Trial Summary

This trial will test the effectiveness of an integrated behavioral activation and fall prevention program delivered by tele-counselors and coaches to low-income homebound seniors. The program will be compared to similar programs delivered by telephone or in person, with the goal of improving access to depression treatment and fall prevention for growing numbers of low-income homebound seniors.

Who is the study for?
This trial is for low-income, homebound seniors over 50 who are struggling with depression and have a risk of falling. They must speak English or Spanish and not be currently receiving psychotherapy or fall prevention programs. Those with substance misuse, high suicide risk, bedbound status, probable dementia, recent changes in antidepressant medication, or bipolar disorder cannot join.Check my eligibility
What is being tested?
The study tests a combined phone-based behavioral activation (BA) therapy and in-home fall prevention (FP) program versus each intervention alone or regular check-in calls as control. Participants will receive sessions through telephone support and at-home visits to see if this improves their mental health and reduces falls.See study design
What are the potential side effects?
Since the interventions involve counseling and coaching rather than medications, side effects may include discomfort from discussing personal issues during BA therapy or potential minor injuries from FP exercises.

TBF Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.

TBF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~monthly (form 12 weeks to 36 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and monthly (form 12 weeks to 36 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes from baseline EuroQol-5D score at 12, 24, and 36 weeks
Changes from baseline depressive symptom at 12, 24, and 36 weeks
Changes from baseline disability score at 12, 24, and 36 weeks
+4 more
Secondary outcome measures
Changes from baseline exercise frequency at 12, 24, and 36 weeks
Changes from baseline fear of falling at 12, 24, and 36 weeks

TBF Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Tele-Behavioral Activation and Fall PreventionExperimental Treatment2 Interventions
Each subject will participate in five 1-hour, weekly Tele-BA sessions followed by four 1-1.5 hour, weekly in-home FP sessions with the same provider
Group II: Tele-Behavioral ActivationExperimental Treatment1 Intervention
Each subject in this arm will participate in five 1-hour, weekly Tele-BA sessions followed by four weekly check-in (booster) calls of up to 30 minutes each.
Group III: Fall PreventionExperimental Treatment1 Intervention
Each subject will participate in four 1-1.5 hour, weekly in-home (or tele, if COVID continues) FP sessions followed by four weekly check-in (booster) calls of up to 30 minutes each.
Group IV: Attention Control (Telephone Support Call)Active Control1 Intervention
AC participants in this study will receive five weekly telephone calls of up to 45 minutes each and four weekly check-in calls of up to 30 minutes each from a research assistant (RA) who will employ genuine regard and attentive listening and provide nonspecific support.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation
2013
Completed Phase 3
~2980

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
80,924 Total Patients Enrolled
Baylor College of MedicineOTHER
1,001 Previous Clinical Trials
6,001,932 Total Patients Enrolled
Namkee G ChoiPrincipal InvestigatorUniversity of Texas at Austin

Media Library

Behavioral Activation Clinical Trial Eligibility Overview. Trial Name: NCT05011864 — N/A
Major Depressive Disorder Research Study Groups: Tele-Behavioral Activation and Fall Prevention, Fall Prevention, Tele-Behavioral Activation, Attention Control (Telephone Support Call)
Major Depressive Disorder Clinical Trial 2023: Behavioral Activation Highlights & Side Effects. Trial Name: NCT05011864 — N/A
Behavioral Activation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05011864 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for enrolment in this clinical trial?

"Clinicaltrials.gov reports this clinical trial is actively recruiting participants, having first been published on November 1st 2021 and most recently revised on May 16th 2022."

Answered by AI

What is the current participant count for this clinical research?

"Affirmative. Per information hosted on clinicaltrials.gov, the medical study is actively recruiting participants and was initially posted in November 2021 before being revised in May 2022. 320 patients are needed from a single centre to fulfil their recruitment goals."

Answered by AI
~168 spots leftby Dec 2026